Abstract:Vinpocetine (VIN), a derivative of vincamine found in the vinca plant, widens blood vessels in the brain and has been shown to improve cognitive function, memory, and cerebrovascular disorders. Nevertheless, the clinical utility of VIN is constrained by factors such as low oral bioavailability owing to the first-pass metabolism that often demands frequent dosing of 3-4 tablets/day. In this regard, the present work aimed to develop VIN-loaded chitosan nanoparticles (VIN-CH-NPs) to surmount these limitations and in view to enhance delivery to the brain of VIN by minimizing systemic exposure. The chitosan (CH) nanoparticles (NP) were developed by ionotropic gelation technique employing tripolyphosphate (TPP) as a cross-linking agent. Employing Design of Experiments (DoE), the effect of CH and TPP concentrations and stirring speed were systematically optimized using Box Behnken design (BBD). The optimized batch of nanoparticles displayed a particle size, zeta potential, entrapment efficiency, and drug loading of 130.6 ± 8.38 nm, +40.81 ± 0.11 mV, 97.56 ± 0.04 %, and 61 ± 0.89 %, respectively. Fourier Transform Infrared Spectroscopy indicated the chemical integrity of the drug ruling out the interaction between the VIN and excipients used. DSC and PXRD data indicated that reduction of the crystallinity of VIN in the chitosan matrix. These VIN-CH-NPs manifested good stability, exhibiting an almost spherical morphology. To mitigate rapid mucociliary clearance upon intranasal administration, the optimized VIN-CH-NPs were incorporated into thermosensitive in situ gel (VIN-CHN-ISG). It was observed that the in-situ gel loaded with nanoparticles was opalescent with a pH level of 5.3 ± 0.38. It was also noted that the gelation temperature was 32 ± 0.89 °C, and the gelation time was approximately 15 s. The drug delivery to the brain through the nasal application of optimized VIN-NPs in situ gel was assessed in rats. The results indicated significant nasal application of the in-situ gel nearly doubled the Cmax (P < 0.05) and AUC0-t (P < 0.05) in the brain compared to oral administration. Nasal administration improved drug delivery to the brain by reducing systemic exposure to VIN. A histopathological study of the nasal mucosa revealed no irritation or toxicity, making it safe for nasal administration. These findings suggest that the developed NPs in-situ gel effectively targeted vinpocetine to the brain through the nasal pathway, providing a potential therapeutic strategy for managing Alzheimer's disease.

Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits

Optimized Preparation of Vinpocetine Micelles and in Vivo Evaluation of Its Pharmacokinetics in Rats.

Preparation and Characterization of Vinpocetine Loaded Nanostructured Lipid Carriers (NLC) for Improved Oral Bioavailability

Potentials of Proniosomes for Improving the Oral Bioavailability of Poorly Water-Soluble Drugs

Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability.

Optimization of Vinpocetine Long-Circulation Liposome Formulation by Box-Behnken Experimental Design

Preparation, evaluation, and NMR characterization of vinpocetine microemulsion for transdermal delivery

Study on Pharmacokinetics and Relative Bioavailability of Puerarin Proliposomes

Preparation and Evaluation of Vinpocetine Self-Emulsifying Ph Gradient Release Pellets.

Improving Breviscapine Oral Bioavailability by Preparing Nanosuspensions, Liposomes and Phospholipid Complexes

Preparation, characterization, and biodistribution of breviscapine proliposomes in heart.

Characterization, Optimization, In Vitro and In Vivo Evaluation of Simvastatin Proliposomes, as a Drug Delivery

Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats

Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes

Cubosomes with Surface Cross-Linked Chitosan Exhibit Sustained Release and Bioavailability Enhancement for Vinpocetine

Preparation of Silymarin Proliposome: A New Way to Increase Oral Bioavailability of Silymarin in Beagle Dogs

Preparation of silymarin proliposomes and its pharmacokinetics in rats]

Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine

Preparation and Evaluation of Puerarin-loaded PLGA Nanoparticles for Improving Oral Bioavailability in SD Rats

Proliposomes for Oral Delivery of Dehydrosilymarin: Preparation and Evaluation in Vitro and in Vivo

Improvement of Oral Availability of Ginseng Fruit Saponins by a Proliposome Delivery System Containing Sodium Deoxycholate